Immunic Inc

General ticker "IMUX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $119.4M

Immunic Inc follows the US Stock Market performance with the rate: 15.8%.

Estimated limits based on current volatility of 3.3%: low 1.01$, high 1.08$

Factors to consider:

  • Price in estimated range
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.04$, 2.88$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.14$, 2.96$]

Financial Metrics affecting the IMUX estimates:

  • Negative: Non-GAAP EPS, $ of -2.11 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -55.60 <= 2.35
  • Positive: Inventory ratio change, % of -100 <= -1.03
  • Positive: Interest expense per share, $ of 0 <= 0

Similar symbols

Short-term IMUX quotes

Long-term IMUX plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $91.67MM $119.49MM $99.22MM
Operating Income $-91.67MM $-119.49MM $-99.22MM
Non-Operating Income $-1.28MM $-0.92MM $5.61MM
Interest Expense $0.00MM $1.04MM $0.00MM
R&D Expense $61.12MM $71.25MM $83.22MM
Income(Loss) $-92.94MM $-120.41MM $-93.61MM
Profit(Loss) $-92.94MM $-120.41MM $-93.61MM
Stockholders Equity $127.11MM $113.68MM $28.93MM
Inventory $2.15MM $2.66MM $0.00MM
Assets $139.10MM $127.75MM $54.30MM
Operating Cash Flow $-83.23MM $-65.14MM $-70.83MM
Capital expenditure $0.07MM $0.11MM $0.33MM
Investing Cash Flow $-0.07MM $-9.74MM $9.46MM
Financing Cash Flow $42.84MM $95.76MM $1.03MM
Earnings Per Share* $-3.92 $-4.85 $-2.11

* EPS are Split Adjusted, recent splits may be reflected with a delay.